IDEAYA Biosciences hosts investor R&D day to highlight oncology pipeline

IDYA•2026-11-04

IDEAYA Biosciences will host an investor R&D day in London on November 16, 2026, covering IDE892 Phase 1 data and RAS-focused combination strategies. CEO Yujiro S. Hata will also join a UBS conference fireside chat that day, and management will participate in a Jefferies conference on November 17.

1. Investor events

IDEAYA Biosciences will host its Investor R&D Day in London on November 16, 2026, at 5 p.m. GMT. The event will cover IDE892 Phase 1 data and RAS-focused combination strategies. CEO Yujiro S. Hata will join the UBS Global Biopharma Conference fireside chat at 10:40 a.m. GMT that day, and management will participate in the Jefferies Global Healthcare Conference on November 17 at 1 p.m. GMT.

IDEAYA Biosciences hosts investor R&D day to highlight oncology pipeline

1. Investor events

Related News

Dynatrace target price cut to $61 from $64 by JPMorgan

H.C. Wainwright initiates coverage of Kardigan with buy rating and $42 target price

American Savings Bank NA: Stephens raises target price to $22 from $21

CL Workshop Group sets 1-for-80 ADS consolidation for Nov. 6

SK Telecom Q3 2026 consolidated profit swings to 411.8 billion won from year-earlier loss